International Alliances Limited has conducted annual surveys since 1999 to determine Japan's most-admired pharmaceutical companies. The latest (the 10th that has been published) was conducted in November of 2008. The full report, available from IAL for 30,000 yen (about $333), analyzes responses by each category of responders, overall replies, and trends over time.
30companies, 15 Japanese, and 15 foreign affiliates were evaluated. They included:
Japanese
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze